Sort by: after hours percent change | delayed percent change | gain open | gain high | gain close | publishing date
symbols : NVO save search
Global Clinical Trials Markets 2022-2028: Globalization of Clinical Trials / Increasing R&D Promoting Outsourcing / Adoption of New Technology in Clinical Research
Published: 2022-06-28 (Crawled : 11:00) - prnewswire.com
ICLR | News | $219.14 -0.79% 0.0% |
|
Health Technology
|
| O: 1.05%
H: 0.96%
C: -0.24%
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
|
| O: -2.98%
H: 0.66%
C: -0.87%
trials research technology
Valued to be $3.4 Billion by 2026, Critical Care Therapeutics Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 12:20) - prnewswire.com
BMY | $78.7 -1.6% 0.38% |
|
Health Technology
|
| O: 0.78%
H: 1.72%
C: 0.95%
BAX | $65.25 -2.19% 0.0% |
|
Health Technology
|
| O: 4.39%
H: 0.97%
C: -0.09%
BMRN | $83.23 -2.19% -0.29% |
|
Health Technology
|
| O: 1.23%
H: 0.57%
C: -1.48%
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
KMDA | $4.54 0.89% 0.0% |
|
Health Technology
|
| O: -1.52%
H: 0.67%
C: -0.88%
ABEO | $0.19 3.77% 1.04% |
|
Health Technology
|
| O: -5.43%
H: 9.2%
C: 5.23%
care for therapeutics growth
Valued to be $12.9 Billion by 2026, Crohn`s Disease (CD) Therapy Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 12:20) - prnewswire.com
JNJ | News | $176.94 -2.84% 0.18% |
|
Health Technology
|
| O: 0.78%
H: 0.94%
C: 0.26%
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
CCXI | $25.08 -3.54% 0.0% |
|
Health Technology
|
| O: -4.88%
H: 1.04%
C: -1.25%
AZN | $65.94 -0.86% 0.21% |
|
Health Technology
|
| O: -0.36%
H: 1.22%
C: 0.38%
AZNCF | $127.2501 |
|
Health Technology
|
| O: -1.55%
H: 4.43%
C: 0.03%
NVS | $84.17 -1.3% 0.17% |
|
Health Technology
|
| O: 1.86%
H: 1.05%
C: 0.24%
PFE | News | $50.66 -2.35% 0.4% |
|
Health Technology
|
| O: 1.46%
H: 1.45%
C: 0.78%
disease for therapy growth
Innate Pharma to Participate in Upcoming Investor Conference - June 23, 2022
Published: 2022-06-23 (Crawled : 07:00) - biospace.com/
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: 1.85%
H: 0.0%
C: 0.0%
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
|
| O: -0.32%
H: 1.34%
C: 1.31%
IPHA | $2.74 1.83% |
|
Health Technology
|
| O: -1.85%
H: 3.02%
C: -1.13%
pharma conference
Echosens and Novo Nordisk Announce Partnership to Increase Awareness and Advance Early Diagnosis of NASH
Published: 2022-06-22 (Crawled : 11:00) - biospace.com/
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
partnership nash
Insulin Market to Exceed US$ 30 Bn by 2031; Global Burden of Diabetes and Complications Propelling Adoption of Therapies, Observes TMR Report
Published: 2022-06-20 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $108.84 |
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
BDX A | $244.53 -2.23% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
| Email alert
Add to watchlist
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
| Email alert
Add to watchlist
report diabetes insulin market
Global Therapeutic Proteins Market Report 2022-2031 Featuring Major Players - Abbott Laboratories; Amgen Inc.; Baxter International Inc.; Eli Lilly and Company; F.Hoffmann-La Roche
Published: 2022-06-20 (Crawled : 15:00) - prnewswire.com
BIIB | $202.53 -5.17% -0.82% |
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $106.97 -1.93% -0.11% |
|
Health Technology
| Email alert
Add to watchlist
AMGN | $243.6 -0.51% 0.47% |
|
Health Technology
| Email alert
Add to watchlist
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $176.94 -2.84% 0.18% |
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $108.84 |
|
Health Technology
| Email alert
Add to watchlist
BAX | $65.25 -2.19% 0.0% |
|
Health Technology
| Email alert
Add to watchlist
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
| Email alert
Add to watchlist
report roche international market
Novo Nordisk A/S – Share repurchase programme
Published: 2022-06-20 (Crawled : 13:00) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
| Email alert
Add to watchlist
repurchase
Novo Nordisk A/S – Share repurchase programme
Published: 2022-06-13 (Crawled : 13:20) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
|
| O: -1.92%
H: 0.28%
C: -1.19%
repurchase
Novo Nordisk A/S: Sogroya® data show potential as once-weekly treatment in children living with growth hormone deficiency
Published: 2022-06-12 (Crawled : 20:20) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
| Email alert
Add to watchlist
sogroya treatment children potential living growth hormone
At 11% CAGR, Global Peptide Therapeutics Market Size is Expected to Reach USD 74 Bn by 2028 Says Zion Market Research - Industry Trends, Share, Value, Analysis & Forecast Report
Published: 2022-06-10 (Crawled : 15:20) - prnewswire.com
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -3.19%
H: 0.0%
C: 0.0%
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
|
| O: -1.6%
H: 0.0%
C: 0.0%
LLY | News S | $317.62 -2.95% -0.03% |
|
Health Technology
|
| O: -1.09%
H: 0.0%
C: 0.0%
GSK | $43.35 -0.8% 0.19% |
|
Health Technology
|
| O: 0.64%
H: 0.0%
C: 0.0%
GLAXF | $21.99 |
|
Health Technology
|
| O: 2.27%
H: 0.0%
C: -0.8%
research report expected therapeutics market
Novo Nordisk A/S – Share repurchase programme
Published: 2022-06-07 (Crawled : 18:00) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
|
| O: 1.85%
H: 1.51%
C: 1.44%
repurchase
Innate Pharma Announces IPH5201 Phase 2 Study in Lung Cancer
Published: 2022-06-03 (Crawled : 08:00) - biospace.com/
IPHA | $2.74 1.83% |
|
Health Technology
|
| O: 2.96%
H: 0.98%
C: -1.15%
SNY | News | $52.13 -0.89% 0.0% |
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
AZN | $65.94 -0.86% 0.21% |
|
Health Technology
|
| O: -0.56%
H: 0.82%
C: -0.64%
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
|
| O: 0.65%
H: 0.63%
C: 0.16%
IPHYF | $2.6 |
|
Health Technology
|
| O: 1.65%
H: 0.0%
C: -0.32%
SNYNF | News | $108.84 |
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
iph5201 pharma cancer
Novo Nordisk achieves primary objectives of ONWARDS 1 and 6 trials with once-weekly insulin icodec demonstrating superior reduction in HbA1c vs insulin glargine U100 in ONWARDS 1
Published: 2022-06-03 (Crawled : 08:00) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
|
| O: 0.65%
H: 0.63%
C: 0.16%
trials glargine insulin
Terns Pharmaceuticals Appoints Kerry Russell as Chief Medical Officer
Published: 2022-06-01 (Crawled : 22:00) - biospace.com/
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
|
| O: 0.35%
H: 0.22%
C: -0.42%
Novo Nordisk A/S – Share repurchase programme
Published: 2022-05-30 (Crawled : 12:00) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
| Email alert
Add to watchlist
repurchase
Growth Hormone Market worth USD 5.5 Billion by 2030, Says Global Market Insights Inc.
Published: 2022-05-18 (Crawled : 11:00) - prnewswire.com
NVS | $84.17 -1.3% 0.17% |
|
Health Technology
|
| O: -0.31%
H: 0.53%
C: -0.19%
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
|
| O: -2.16%
H: 0.43%
C: -1.08%
growth market hormone
Novo Nordisk A/S: Share repurchase programme
Published: 2022-05-16 (Crawled : 14:20) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
|
| O: -2.14%
H: 1.02%
C: 0.02%
repurchase
Novo Holdings Portfolio Company F2G enters strategic collaboration with Shionogi to commercialise its new antifungal agent Olorofim in Europe and Asia
Published: 2022-05-16 (Crawled : 08:00) - prnewswire.com
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
|
| O: -2.14%
H: 1.02%
C: 0.02%
europe collaboration
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2022-05-11 (Crawled : 14:00) - globenewswire.com
NVO | News | $108.3 -4.07% 2.17% |
|
Health Technology
|
| O: -2.55%
H: 2.32%
C: -0.85%
Your saved searches
Save your searches and get alerts when important news are released.
Mentioned Today
ACN | News | $283.8 -3.01% 0.07% |
|
Technology Services
BTG | News | $3.56 -2.73% 0.84% |
|
Non-Energy Minerals
DELL | News | $48.94 -2.59% 0.0% |
|
Electronic Technology
DKILF | News | $166.37 |
|
Producer Manufacturing
DKILY | News | $16.05 |
|
Manufacturing
GBERF | News | $546.0 |
|
Producer Manufacturing
GBERY | News | $49.49 |
|
Manufacturing
GLPI | News 0 d | $46.68 -0.09% 0.0% |
|
Finance
INCY | News | $75.64 -2.22% 0.93% |
|
Health Technology
JCI | News | $48.44 -0.43% 0.0% |
|
Producer Manufacturing
JTEKF | News | $ 0% |
|
Producer Manufacturing
JTEKY | News | $24.29 |
|
Manufacturing
LEA | News | $134.75 0.57% 0.0% |
|
Producer Manufacturing
LLY | News 4 | $317.62 -2.95% -0.03% |
|
Health Technology
NDAQ | News 4 | $154.64 -2.08% -0.23% |
|
Finance
PCRFF | News | $8.15 |
|
n/a
PCRFY | News | $8.22 |
|
n/a
PPRUF | News | $534.0 |
|
Consumer Non-Durables
PPRUY | News | $52.24 |
|
Manufacturing
TMO | News | $535.77 -1.45% -0.09% |
|
Health Technology